The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of complement factor H (CFH) inhibitor GT103 in advanced non-small cell lung cancer (NSCLC): Results of a phase Ib first in human dose escalation study.
 
Hirva Mamdani
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca (I); Daiichi Sankyo/Astra Zeneca; Genentech; MorphoSys (I); Seagen (I); Zentalis
Speakers' Bureau - BeiGene (I)
Research Funding - AstraZeneca (Inst)
 
Jeffrey Melson Clarke
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Corbus; G1 Therapeutics; Genentech; Merck; Novartis; Pfizer; Sanofi; Spectrum Pharmaceuticals; Turning Point Therapeutics; Vivacitas Oncology
Speakers' Bureau - AstraZeneca
Research Funding - Achilles Therapeutics (Inst); Adaptimmune (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cellular Biomedicine Group (Inst); Genentech (Inst); Grid Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Spectrum Pharmaceuticals (Inst)
(OPTIONAL) Uncompensated Relationships - Lung Cancer Initiative of North Carolina
 
Lin Gu
No Relationships to Disclose
 
Tom Stinchcombe
Consulting or Advisory Role - Abbvie; AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Coherus Biosciences; G1 Therapeutics; Gilead Sciences; Pfizer; Spectrum Pharmaceuticals; Takeda
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); Mirati Therapeutics (Inst); Nuvalent, Inc. (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Pfizer
Other Relationship - Genentech; GlaxoSmithKline
 
Jeffrey Crawford
Consulting or Advisory Role - AstraZeneca; BeyondSpring Pharmaceuticals; BioAtla; Enzychem Lifesciences; G1 Therapeutics; Genentech; Jazz Pharmaceuticals; Merck; Partner Therapeutics; Pfizer
Research Funding - AstraZeneca (Inst); Helsinn Healthcare (Inst); Pfizer (Inst)
 
Scott Joseph Antonia
Consulting or Advisory Role - Achilles Therapeutics; Guardian Bio; Immutep; Leap Therapeutics; Memgen; RAPT Therapeutics; Shoreline; Tubulis GmbH; xilis
Patents, Royalties, Other Intellectual Property - Oncolytic virus
Travel, Accommodations, Expenses - Achilles Therapeutics; Amgen; Celsius Therapeutics; RAPT Therapeutics
 
Michael Campa
Stock and Other Ownership Interests - Grid Therapeutics
Consulting or Advisory Role - Grid Therapeutics
Patents, Royalties, Other Intellectual Property - I am an inventor on a patent held by Duke that will be licensed by Grid Therapeutics.
 
Andrew B. Nixon
Consulting or Advisory Role - Leap Therapeutics; Sanofi
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Genmab (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Patent (Inst); Patent Pending (Inst)
 
Guru P. Sonpavde
Employment - Myriad Genetics (I)
Honoraria - Grand Rounds in Urology; Ideology Health; Onviv; PeerView; PrecisCa; UpToDate
Consulting or Advisory Role - Aktis Oncology; Astellas Pharma; Bicycle Therapeutics; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; EMD Serono; Exelixis; G1 Therapeutics; Genentech; Gilead Sciences; Janssen; Kura Oncology; Loxo/Lilly; Loxo/Lilly; Lucence; Merck; Pfizer; Scholar Rock; Seagen; Syapse; Vial
Speakers' Bureau - Astellas Pharma; AVEO; Bayer; Exelixis; Gilead Sciences; INFORMAÇÃO BRASILEIRA DE ONCOLOGIA; Janssen Oncology; Medscape; Merck; Natera; Pfizer; Research to Practice; Seagen
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst); Gilead Sciences (Inst); Jazz Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb
Other Relationship - Bristol-Myers Squibb; Elsevier; G1 Therapeutics; Mereo BioPharma; QED Therapeutics
 
George R. Simon
Consulting or Advisory Role - AstraZeneca; Genprex; Onc.AI; Reflexion Medical
Speakers' Bureau - AstraZeneca; OncLive
 
Neal E. Ready
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Celgene; G1 Therapeutics; Jazz Pharmaceuticals; Merck; Merck Serono; Novartis; Pfizer; Regeneron; Sanofi/Regeneron
Speakers' Bureau - Bristol-Myers Squibb; Jazz Pharmaceuticals
Research Funding - Bristol-Myers Squibb; Memgen (Inst); Merck
 
JAMES E HERNDON
No Relationships to Disclose
 
Edward F. Patz
No Relationships to Disclose